Baby Minder is the first device of its kind to deliver continuous, objective neuromotor monitoring for infants and toddlers—both at home and in clinical settings. It fills a critical gap in early childhood neurological care across Brazil and Latin America, where short hospital stays and limited specialist access often delay diagnosis. Using advanced computer vision, Baby Minder detects subtle signs of conditions like autism, epilepsy, and cerebral palsy that traditional methods may miss. Backed by Eurofarma and in use at Jundiaí University Hospital through Brazil’s public system (SUS), it’s a scalable, accessible tool that enables earlier detection and faster intervention.